Patrick Legembre

7.2k citations

77 papers · 2.3k indexed · h-index 29

Impact in

Immunology top 5%
- Phagocytosis and Immune Regulation
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Cancer Research top 5%
- NF-κB Signaling Pathways

Papers in ⓘ

Immunology 37
- Phagocytosis and Immune Regulation 11
- Immune Cell Function and Interaction 10
- Immune Response and Inflammation 10
- Immunotherapy and Immune Responses 7
Immunology and Allergy 8
- Cell Adhesion Molecules Research 8

Co-authors: Marcus E. Peter (8 shared papers)Bryan C. Barnhart (6 shared papers)Jean‐François Moreau (14 shared papers)Eric M. Pietras (2 shared papers)Sophie Daburon (12 shared papers)Jean‐Philippe Guégan (7 shared papers)Guido Franzoso (1 shared paper)Concetta Bubici (1 shared paper)
Journals: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (4 papers)Cell Death and Differentiation (4 papers)PLoS ONE (4 papers)The Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: France United States Morocco

In The Last Decade

Patrick Legembre

75 papers receiving 2.3k citations

Peers

Countries citing papers authored by Patrick Legembre

Since Specialization

Citations

This map shows the geographic impact of Patrick Legembre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Legembre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Legembre more than expected).

Fields of papers citing papers by Patrick Legembre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Legembre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Legembre. The network helps show where Patrick Legembre may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Legembre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Legembre Line = papers co-authored together Patrick Legembre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells The EMBO Journal ·Bryan C. Barnhart, Patrick Legembre, Eric M. Pietras, Concetta Bubici, Guido Franzoso, Marcus E. Peter	2004	226
2	Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy Nature Communications ·Susan E. Logue, Eoghan P. McGrath, Patricia A. Cleary, Stephanie Greene, Katarzyna Mnich, Aitor Almanza, Éric Chevet, Róisín M. Dwyer, Anup Mammen Oommen, Patrick Legembre, Florence Godey, Emma C. Madden, Brian Leuzzi, Joanna Obacz, Qingping Zeng, John B. Patterson, Richard Jäger, Adrienne M. Gorman, Afshin Samali	2018	214
3	Two CD95 tumor classes with different sensitivities to antitumor drugs Proceedings of the National Academy of Sciences ·Alicia Algeciras-Schimnich, Eric M. Pietras, Bryan C. Barnhart, Patrick Legembre, Shrijay Vijayan, Susan L. Holbeck, Marcus E. Peter	2003	87
4	The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway PLoS Biology ·Sébastien Tauzin, Benjamin Chaigne-Delalande, Éric Selva, Nadine Khadra, Sophie Daburon, Cécile Contin‐Bordes, Patrick Blanco, Jacques Le Seyec, Thomas Ducret, Laurent Counillon, Jean‐François Moreau, Paul Hofman, Pierre Vacher, Patrick Legembre	2011	81
5	Induction of apoptosis and activation of NF‐κB by CD95 require different signalling thresholds EMBO Reports ·Patrick Legembre, Bryan C. Barnhart, Lixin Zheng, Shrijay Vijayan, Stephen E. Straus, Jennifer M. Puck, Janet K. Dale, Michael J. Lenardo, Marcus E. Peter	2004	80
6	Does CD95 have tumor promoting activities? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Marcus E. Peter, Patrick Legembre, Bryan C. Barnhart	2005	79
7	Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility Oncogene ·Valérie Edmond, Florent Dufour, Guillaume Poiroux, Kenji F. Shoji, Marine Malleter, Amélie Fouqué, Sébastien Tauzin, Ruth Rimokh, Odile Sergent, Aubin Penna, Aude Dupuy, Thierry Levade, Nathalie Théret, Olivier Micheau, Bruno Ségui, Patrick Legembre	2014	77
8	S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand–Mediated Apoptosis in Cancer Cells Gastroenterology ·Lissbeth Leon-Bollotte, S. Selvakumar, Olivier Cauvard, Stéphanie Plenchette, Catherine Paul, Cindy Godard, Antonio Martínez‐Ruiz, Patrick Legembre, Jean‐François Jeannin, Ali Bettaı̈eb	2011	74
9	CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer Cancer Research ·Marine Malleter, Sébastien Tauzin, Alban Bessede, Rémy Castellano, Armelle Goubard, Florence Godey, Jean Lévêque, Pascal Jézéquel, L. Campion, Mario Campone, Thomas Ducret, Gaëtan MacGrogan, Laure Debure, Yves Collette, Pierre Vacher, Patrick Legembre	2013	69
10	TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress Oncotarget ·Florent Dufour, Thibault Rattier, Andrei Constantinescu, Luciana Zischler, Aymeric Morlé, Hazem Ben Mabrouk, Étienne Humblin, Guillaume Jacquemin, Éva Szegezdi, Fabien Delacôte, Naziha Marrakchi, Gilles Guichard, Catherine Pellat‐Deceunynck, Pierre Vacher, Patrick Legembre, Carmen Garrido, Olivier Micheau	2016	64
11	Nonapoptotic functions of Fas/CD95 in the immune response FEBS Journal ·Jean‐Philippe Guégan, Patrick Legembre	2017	63
12	CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases Frontiers in Immunology ·Matthieu Le Gallo, Amanda Poissonnier, Patrick Blanco, Patrick Legembre	2017	60
13	Identification of SNF1/AMP Kinase-related Kinase as an NF-κB-regulated Anti-apoptotic Kinase Involved in CD95-induced Motility and Invasiveness Journal of Biological Chemistry ·Patrick Legembre, Robert Schickel, Bryan C. Barnhart, Marcus E. Peter	2004	57
14	Cutting Edge: Modulation of Fas-Mediated Apoptosis by Lipid Rafts in T Lymphocytes The Journal of Immunology ·Patrick Legembre, Sophie Daburon, Patrick Moreau, Jean-François Moreau, Jean‐Luc Taupin	2006	51
15	CD95 triggers Orai1-mediated localized Ca²⁺entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation Proceedings of the National Academy of Sciences ·Nadine Khadra, Laurence Bresson‐Bepoldin, Aubin Penna, Benjamin Chaigne-Delalande, Bruno Ségui, Thierry Levade, Anne-Marie Vacher, Josy Reiffers, Thomas Ducret, Jean‐François Moreau, Michael D. Cahalan, Pierre Vacher, Patrick Legembre	2011	46
16	Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells European Journal of Cancer ·Amélie Rébillard, Sandrine Jouan-Lanhouet, Elodie Jouan, Patrick Legembre, Mathieu Pizon, Odile Sergent, David Gilot, Xavier Tekpli, Dominique Lagadic‐Gossmann, Marie‐Thérèse Dimanche‐Boitrel	2010	41
17	The CD95/CD95L signaling pathway: A role in carcinogenesis Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Amélie Fouqué, Laure Debure, Patrick Legembre	2014	40
18	Localization of Fas/CD95 into the Lipid Rafts on Down-Modulation of the Phosphatidylinositol 3-Kinase Signaling Pathway Molecular Cancer Research ·Marie Bénéteau, Mathieu Pizon, Benjamin Chaigne-Delalande, Sophie Daburon, Patrick Moreau, Francesca De Giorgi, François Ichas, Amélie Rébillard, Marie‐Thérèse Dimanche‐Boitrel, Jean‐Luc Taupin, Jean‐François Moreau, Patrick Legembre	2008	39
19	CD95-mediated cell signaling in cancer: mutations and post-translational modulations Cellular and Molecular Life Sciences ·Sébastien Tauzin, Laure Debure, Jean‐François Moreau, Patrick Legembre	2011	39
20	The apoptotic members CD95, BclxL, and Bcl-2 cooperate to promote cell migration by inducing Ca2+ flux from the endoplasmic reticulum to mitochondria Cell Death and Differentiation ·Amélie Fouqué, Eléonore Lepvrier, Laure Debure, Yves Gouriou, Marine Malleter, Vanessa Delcroix, Michel Ovize, Thomas Ducret, Chenqi Li, Mehdi Hammadi, Pierre Vacher, Patrick Legembre	2016	36

About Patrick Legembre

Patrick Legembre is a scholar working on Immunology, Immunology and Allergy, Molecular Biology, Transplantation and Toxicology, having authored 77 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (41 papers), RNA Interference and Gene Delivery (14 papers), Phagocytosis and Immune Regulation (11 papers), Immune Cell Function and Interaction (10 papers), Immune Response and Inflammation (10 papers), Cell Adhesion Molecules Research (8 papers), Immunotherapy and Immune Responses (7 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Immunology (801 citations), Cancer Research (361 citations), Molecular Biology (1.6k citations), Cell Biology (338 citations) and Oncology (394 citations). Patrick Legembre has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Marcus E. Peter, Bryan C. Barnhart, Jean‐François Moreau, Eric M. Pietras, Sophie Daburon, Jean‐Philippe Guégan, Guido Franzoso, Concetta Bubici, Pierre Vacher and Benjamin Chaigne-Delalande. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Cell Death and Differentiation, PLoS ONE, The Journal of Immunology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact